Paragraph IV Disputes

Expert Insights on Hatch-Waxman Litigation Strategies for Brand Names and Generics

05/03/2012 - 05/04/2012

This two-day conference is designed to help in-house counsel and executives from pharmaceutical, biotech and biopharmaceutical companies conquer the latest patent litigation challenges surrounding brand name and generics.

Asim Bhansali will present, "Parallel Proceedings in Paragraph IV Disputes: Strategies for Balancing and Streamlining Proceedings Before Federal Courts, PTO and ITC." His panel will examine the different forums and proceedings before which Paragraph IV litigants may seek simultaneous redress.

This event — which is widely recognized for setting the standards for Paragraph IV litigation and which also serves as the annual meeting place for the “who’s who” of pharmaceutical patent litigation — is now the single forum on which brand name and generic companies can rely for answers during this turbulent time in which the balance of power designed by the Hatch-Waxman Act may completely unravel.

For more information, please visit the conference's website at this link.

Organization: American Conference Institute

Location: Marriott Downtown, New York City, NY